DUBLIN, May 09, 2022--(BUSINESS WIRE)--The "Global Spinal Fusion Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

This report provides a detailed analysis of the global spinal fusion device Industry. The global spinal fusion device market is projected to reach US$ 9.93 Billion by 2027, US$ 7.48 Billion in 2021.

The incidence of spinal cord injuries has grown significantly in the last couple of years. According to the World Health Organization (WHO), every year, around the world, between 250,000 and 500,000 people suffer an (SCI) spinal cord injury, which raises the demand for spinal fusion devices worldwide.

Spinal fusion devices are utilized to provide stability to the spinal structure, which has lost stability due to degenerative disorders, fracture of the spine, trauma, tumors, and deformity. Besides, spinal fusion devices have innovative locking screw systems and mechanisms which can have self-tapping functions and self-drilling. They are made from modern manufacturing material such as titanium alloy and single and double holes per vertebrae through which the screw fixation is done.

The primary factors attributing to the global spinal surgery market's growth are:

Advances in spinal surgery tools.

Growing geriatric and obese population with spinal deformities.

Increasing demand for non-invasive spinal surgery procedures elements driving the market's growth.

Apart from this, increased research on biologics, especially Bone Morphogenetic Proteins (BMPs), is expected to favor the adoption of spinal fusion implants. According to this report Global Spinal Fusion Device Market Size was US$ 7.48 Billion in 2021.

North America is a significant Spinal Fusion Device Market

Regionally, North American is the significant spinal fusion device market, owing to increased spinal disorders. By (NCHS) National Center for Health Statistics, more than 65 Million Americans suffer from lower back problems every year. With evolving lifestyle and food consumption methods in the region, such figures will increase further.

The degenerative spinal disorders are also to grow, along with a likely increase in spinal problems in obese populations due to increased obesity, further boosting the spinal fusion device market growth.

Moreover, the Asia Pacific spinal fusion devices market is to significantly growing due to the rising awareness, improving healthcare infrastructure, enhancing reimbursement scenario, and the growing insurance coverage in several APAC countries.

The effect of the COVID-19 pandemic has been witnessed in about every industry. Like other healthcare industries, the market for spinal fusion devices has also been entirely affected. The COVID-19 outbreak situation across countries has shown some challenges on the spinal fusion devices owed to hold on orthopedic services by the hospitals and clinics.

The immense pressure on the hospitals in providing services to COVID-19 patients is also one of the factors, which has been inhibiting the clinics and hospitals in delivering spine fusion services.

Product Type - Market Breakup has been covered from 4 viewpoints

Surgery Type - Market Breakup has been covered from 2 viewpoints

Disease Indicator - Market Breakup has been covered from 4 viewpoints

End Users - Market Breakup has been covered from 3 viewpoints

Regions - Market Breakup has been covered from 5 viewpoints

For more information about this report visit https://www.researchandmarkets.com/r/3z5isi

View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005755/en/

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

With that as a backdrop, let's consider two biotech stocks that don't grab a lot of headlines but deserve serious consideration: Incyte (NASDAQ: INCY) and Axsome Therapeutics (NASDAQ: AXSM). Incyte is a drugmaker with a particular focus on the field of oncology. Its best-selling product is called Jakafi, which treats some types of bone marrow cancer, among other conditions.

Cabaletta Bio Inc (NASDAQ: CABA) presented updated data from the DesCAARTes trial, evaluating DSG3-CAART in adults with mucosal-dominant pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. No dose-limiting toxicities were observed within three months of DSG3-CAART infusion through cohort A4 (2.5 billion cells). There was a dose-dependent increase in DSG3-CAART persistence through day 29 in cohorts A1 to A4, indicating that DSG3-CAART cells were not eliminated throu

Dr. Yashica Robinson, Board member of Physicians for Reproductive Health and the director of the Alabama Women’s Wellness Center testified today in front of the House Judiciary Committee hearing to examine abortion access and care across the country. Robinson is the head of one of the last few abortion clinics in her state. While speaking before the committee Robinson emphasized the importance of abortion as essential health care.

Companies that collect data from the digital clues people leave online often know their most sensitive health information _ gleaned from web searches, health apps and location trackers

To new parents, many things are terrifying—yet few of them are as scary as Sudden Infant Death Syndrome, or SIDS. Much of how and why SIDS occurs is still unknown, but a new piece of research, published last week in eBioMedicine, found clues suggesting that there might be a biological component to it. Compared to other babies, both living and who died of other causes, infants who died of SIDS were consistently found to have lower levels of butyrylcholinesterase, an enzyme that helps provide arousal from sleep.

Eileen Wassermann struggles to calculate her daily risks at this stage of the coronavirus pandemic - with infections drastically undercounted and mask mandates gone. The immunocompromised 69-year-old ensconces herself in her SUV for the half-hour ferry ride across the Puget Sound from her home on Bainbridge Island to Seattle, where she undergoes treatment for the rare inflammatory condition sarcoidosis.Subscribe to The Post Most newsletter for the most important and interesting stories from The

A rehabilitation services provider describes the cycle that keeps people homeless, incarcerated and untreated for their mental illness.

Rebel Wilson declared 2020 her "year of health." Now, she's lost 77 pounds, thanks to a combination of walking and a high-protein diet. Here's how she did it:

The stock market continues to be under pressure due to geopolitical tensions and various economic problems. For instance, cancer-focused biotech company Exelixis (NASDAQ: EXEL) has run circles around the broader market year to date. Can Exelixis continue beating the market from here on out?

Monkeypox is a viral infection that shares similarities with smallpox

WASHINGTON (AP) — At the center of the nationwide baby formula shortage is a single factory: Abbott Nutrition’s plant that […] The post EXPLAINER: What we know about shuttered baby formula plant appeared first on TheGrio.

In the immediate aftermath of a high-profile suicide of a beloved celebrity like Naomi Judd, calls to suicide-prevention hotlines tend to increase.

COVID-19 cases are increasing in the United States – and could get even worse over the coming months, federal health officials warned Wednesday in urging areas hardest hit to consider reissuing calls for indoor masking.

A handful of cases of monkeypox have now been reported or are suspected in the United Kingdom, Portugal and Spain. The outbreaks are raising alarm because the disease mostly occurs in west and central Africa, and only very occasionally spreads elsewhere. Monkeypox is a virus that causes fever symptoms as well as a distinctive bumpy rash.

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and disorders, today announced seven posters on behalf of XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride

Speaker Nancy Pelosi (D-Calif.) Tuesday suggested there could be indictments for the people found to be responsible for the deaths of two infants who consumed baby formula that may have been contaminated. Speaking at a press conference to unveil Democrats’ $28 million aid bill to help put formula back on store shelves, Pelosi said the…

Cases have recently been reported in Britain, Portugal, and Spain, according to the AP and Stat News.

COVID-19 is evolving faster than ever before. Experts warn that the time has come to rethink our reliance on the vaccine status quo and double down on next-generation vaccines that can actually stop infection.

Findings point to importance of cannabis-specific prevention and treatment efforts, scientists say

Birmingham catering assistant Amie Walton desperately wants “just a little” bit more time with her beloved children Harry, eight, and Mia, six